Skip to main content

Ovarian cancer: where are we going with Immunotherapy?

By 12 Dicembre 2019Maggio 18th, 2021No Comments
Temi

Immunotherapy Bridge 2019 in Naples was also about ovarian cancer. Kunle Odunsi (Cancer Center Deputy Director, The M. Steven Piver Professor and Chair, Department of Gynaecologic Oncology, Executive Director, Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York) tells us about the application of immunotherapy in the worst prognosis gynecological malignancy.